Graf Akcie ARNA (Arena Pharmaceuticals Inc). Diskuze k akciím ARNA. Aktuální informace ARNA.

Základní informace o společnosti Arena Pharmaceuticals Inc (Akcie ARNA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 3.77B
Hodnota podniku (EV) 2.78B
Tržby 57.000k
EBITDA -506.60
Zisk -484.11
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.39
EV/Sales 48,693.26
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.23
Price/Sales 66,201.45
P/FCF N/A
Price/Book 3.49
Účetní hodnota na akcii 18.25
Hotovost na akcii 18.65
FCF vůči ceně -10.49 %
Počet zaměstnanců 363
Tržba na zaměstnance 157.02
Profit margin -126,875.86 %
Operating margin -895,591.23 %
Gross margin 100.00 %
EBIT margin -841,703.51 %
EBITDA margin -888,777.19 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 49.07 %
EPS - Očekávaný růst příští rok 49.70 %
Return on assets -40.90 %
Return on equity -44.96 %
ROIC -33.85 %
ROCE -47.04 %
Dluhy/Equity 0.10
Čistý dluh/EBITDA 8.20
Current ratio 15.28
Quick Ratio 15.28
Volatilita 3.38
Beta 1.02
RSI 65.02
Cílová cena analytiků 95
Známka akcie (dle analytiků) 1.00
Insider ownership 0.27 %
Institutional ownership 94.16 %
Počet akcií 61.074M
Procento shortovaných akcií 5.90 %
Short ratio 8.11 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie ARNA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$806.431$17.97$21.337$92.163$13.398$36.97
Cost Of Goods Sold-----$7.759
Gross Profit$806.431$17.97$21.337$92.163$13.398$29.211
Research And Development Expenses$231.496$115.029$70.988$63.782$83.283$100.347
SG&A Expenses$92.189$47.724$30.341$27.529$30.281$34.137
Other Operating Income Or Expenses------
Operating Expenses$323.685$162.753$113.304$97.426$116.91$142.243
Operating Income$482.746$-144.783$-91.967$-5.263$-103.512$-105.273
Total Non-Operating Income/Expense$25.142$5.949$-3.887$-7.037$-7.195$44.765
Pre-Tax Income$507.888$-138.834$-95.854$-12.3$-110.707$-60.508
Income Taxes$110.333$-110.265----
Income After Taxes$397.555$-28.569$-95.854$-12.3$-110.707$-60.508
Other Income------
Income From Continuous Operations$397.555$-28.569$-95.854$-12.3$-110.707$-60.508
Income From Discontinued Operations-$-0.83$3.122$-10.596$2.728-
Net Income$397.555$-29.399$-91.407$-22.516$-107.979$-60.508
EBITDA$480.441$-141.578$-87.553$-0.133$-97.946$-95.976
EBIT$482.746$-144.783$-91.967$-5.263$-103.512$-105.273
Basic Shares Outstanding504733242422
Shares Outstanding524733242422
Basic EPS$7.99$-0.63$-2.77$-0.93$-4.49$-2.80
EPS - Earnings Per Share$7.69$-0.63$-2.77$-0.93$-4.49$-2.80
# 2020 2019 2018 2017 2016 2015
Current Ratio16.899815.39963.8891.87683.5042.7003
Long-term Debt / Capital0.04080.07540.2180.60450.54930.5904
Debt/Equity Ratio0.04610.08690.29811.61571.27461.4941
Gross Margin10010010010010079.0127
Operating Margin59.862-805.6927-431.0212-5.7105-772.5929-284.7525
EBIT Margin59.862-805.6927-431.0212-5.7105-772.5929-284.7525
EBITDA Margin59.5762-787.8575-410.3342-0.1443-731.0493-259.6051
Pre-Tax Profit Margin62.9797-772.5877-449.2384-13.3459-826.2949-163.6679
Net Profit Margin49.2981-163.6005-428.3967-24.4306-805.9337-163.6678
Asset Turnover0.68680.02620.06290.54530.05220.1338
Inventory Turnover Ratio-----0.7164
Receiveable Turnover487.56413.53321.4836160.84292.71549.9596
Days Sales In Receivables0.7486103.305246.02472.2693134.416336.6481
ROE - Return On Equity37.1039-4.7124-46.2741-30.4493-206.7664-127.8023
Return On Tangible Equity37.1039-4.7124-46.2741-30.4493-241.8927-155.6956
ROA - Return On Assets33.8597-4.1591-28.2526-7.2777-43.1116-21.8927
ROI - Return On Investment35.5888-4.3571-36.1861-12.0419-93.1807-52.3471
Book Value Per Share21.356312.26675.27341.65962.20452.1489
Operating Cash Flow Per Share13.8109-0.79050.50841.54820.5379-7.9525
Free Cash Flow Per Share13.7324-0.82570.52321.50760.9873-7.9381

Porovnání s konkurencí: Akcie ARNA

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ARNA N/A 0.23 N/A % 49.70 % -44.96 % 3.49 -126,875.86 %
Akcie ADRO N/A N/A 90.87 % -44.62 % -101.73 % 3.61 N/A %
Akcie ACOR N/A N/A -5.03 % 13.04 % -55.69 % 0.22 -65.11 %
Akcie ATHX 0.00 N/A N/A % -18.18 % -258.36 % 9.28 -5,469.79 %
Akcie GSK 16.60 3.36 N/A % -14.00 % 29.69 % 4.85 16.86 %

Nedávné obchody insiderů: Akcie ARNA

Jméno Obchod Cena Objem
Amit Munshi
President and CEO
Prodej
8 Dec 2020
$70.00 $456,190
Jayson Donald Alexander Dallas
Director
Nákup
8 Dec 2020
$66.25 $331
Jayson Donald Alexander Dallas
Director
Nákup
11 Dec 2020
$69.31 $347
Amit Munshi
President and CEO
Option
7 Jan 2021
$77.59 $1,815,606
Vincent Aurentz
Executive VP and CBO
Option
7 Jan 2021
$77.59 $1,396,620
Robert Lisicki
EVP and Chief Commercial Officer
Option
7 Jan 2021
$77.59 $977,634
Amit Munshi
President and CEO
Prodej
12 Jan 2021
$75.12 $1,117,560
Amit Munshi
President and CEO
Option
15 Jan 2021
$15.50 $1,550,000
Jayson Donald Alexander Dallas
Director
Prodej
19 Jan 2021
$80.50 $106,824
Robert Lisicki
EVP and Chief Commercial Officer
Option
2 Feb 2021
$40.95 $716,625
Vincent Aurentz
Executive VP and CBO
Option
16 Feb 2021
$14.80 $37,355

Diskuze k akciím ARNA